Combination therapy with didanosine and interferon-α in human immunodeficiency virus-infected patients: Results of a phase I/II trial

Journal of Infectious Diseases

Volumn 173, Issue 4, 1996, Pages 840-848

  Kovacs, Joseph A ^a   Bechtel, Chris ^a   Davey Jr , Richard T ^a   Falloon, Judith ^a   Polis, Michael A ^a   Walker, Robert E ^a   Metcalf, Julia A ^a   Davey, Victoria ^a   Piscitelli, Stephen C ^a   Baseler, Michael ^a   Dewar, Robin ^a   Salzman, Norman P ^a   Masur, Henry ^a   Lane, H Clifford ^a  

^a MSC 1662 ^*

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; DIDANOSINE; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MALE; PANCREATITIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 19144370922     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.4.840     Document Type: Article

References (5)

1. Ho DD, Hartshorn KL, Rota TR, et al. Recombinant human interferon alfa-A suppresses HTLV-III replication in vitro. Lancet 1985;1:602-4.
2. Lane HC, Kovacs JA, Feinberg J, et al. Anti-retroviral effects of interferon-α in AIDS-associated Kaposi's sarcoma. Lancet 1988;2:1218-22.
3. de Wit R, Schattenkerk JKME, Boucher CAB, Bakker PJM, Veenhof KHN, Danner SA. Clinical and virological effects of high-dose recombinant interferon-α in disseminated AIDS-related Kaposi's sarcoma. Lancet 1988;2:1214-7.
4. Lane HC, Davey V, Kovacs JA, et al. Interferon-α in patients with asymptomatic human immunodeficiency virus (HIV) infection. Ann Intern Med 1990;112:805-11.
5. Friedland GH, Klein RS, Saltzman BR, et al: A randomized placebocontrolled trial of recombinant human interferon alpha 2a in patients with AIDS. J Acquir Immune Defic Syndr 1988;1:111-8.